FIA
CFRX

FNY Investment Advisers’s ContraFect Corporation CFRX Stock Holding History

FNY Investment Advisers’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6
Closed – – 844
2022
Q4 		$0 Sell
6
-19
-76% -$220 ﹤0.01% 913
2022
Q3 		$0 Buy
+25
New +$1.26K ﹤0.01% 984

Other funds holding CFRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

FNY Investment Advisers's CFRX Position: Q1 2023 in Review

FNY Investment Advisers sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 6 shares.

FNY Investment Advisers first reported a position in CFRX in Q3 2022 and held it in 2 quarters. The position peaked at $0 in Q4 2022. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

  • FNY Investment Advisers reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
  • FNY Investment Advisers sold 6 ContraFect Corporation shares in Q1 2023.
  • FNY Investment Advisers first reported a position in ContraFect Corporation in Q3 2022 and held it in 2 quarters.
  • FNY Investment Advisers's ContraFect Corporation position peaked at $0 in Q4 2022.
  • 19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on FNY Investment Advisers's 13F filing for Q1 2023, filed 12 Apr 2023.